Curative Biotechnology, Inc. (CUBT)
USD 0.01
(5.93%)
USD 0.01
(5.93%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 2.6 Million USD | 24.6% |
| 2022 | 2.08 Million USD | -13.39% |
| 2021 | 2.41 Million USD | 6.07% |
| 2020 | 2.27 Million USD | 5617.42% |
| 2019 | 39.77 Thousand USD | -11.76% |
| 2018 | 45.07 Thousand USD | -23.55% |
| 2017 | 58.95 Thousand USD | -10.55% |
| 2016 | 65.9 Thousand USD | -3.32% |
| 2015 | 68.17 Thousand USD | -63.58% |
| 2014 | 187.19 Thousand USD | -18.03% |
| 2013 | 228.37 Thousand USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 2.39 Million USD | -8.01% |
| 2024 Q2 | 2.42 Million USD | 1.39% |
| 2023 Q2 | 2.16 Million USD | 1.48% |
| 2023 Q3 | 2.2 Million USD | 2.0% |
| 2023 Q1 | 2.13 Million USD | 2.06% |
| 2023 FY | 2.6 Million USD | 24.6% |
| 2023 Q4 | 2.6 Million USD | 17.96% |
| 2022 Q2 | 2.03 Million USD | -7.41% |
| 2022 Q4 | 2.08 Million USD | 4.02% |
| 2022 Q3 | 2 Million USD | -1.25% |
| 2022 FY | 2.08 Million USD | -13.39% |
| 2022 Q1 | 2.19 Million USD | -8.94% |
| 2021 Q1 | 699.92 Thousand USD | -69.22% |
| 2021 FY | 2.41 Million USD | 6.07% |
| 2021 Q4 | 2.41 Million USD | 152.52% |
| 2021 Q3 | 955.23 Thousand USD | 7.36% |
| 2021 Q2 | 889.74 Thousand USD | 27.12% |
| 2020 Q4 | 2.27 Million USD | 4754.94% |
| 2020 Q1 | 38.45 Thousand USD | -3.33% |
| 2020 Q2 | 37.12 Thousand USD | -3.45% |
| 2020 FY | 2.27 Million USD | 5617.42% |
| 2020 Q3 | 46.84 Thousand USD | 26.17% |
| 2019 Q4 | 39.77 Thousand USD | 0.0% |
| 2019 FY | 39.77 Thousand USD | -11.76% |
| 2018 FY | 45.07 Thousand USD | -23.55% |
| 2017 FY | 58.95 Thousand USD | -10.55% |
| 2016 FY | 65.9 Thousand USD | -3.32% |
| 2015 FY | 68.17 Thousand USD | -63.58% |
| 2014 Q1 | 220.6 Thousand USD | -3.4% |
| 2014 FY | 187.19 Thousand USD | -18.03% |
| 2013 Q1 | 205.71 Thousand USD | 0.0% |
| 2013 Q4 | 228.37 Thousand USD | 0.0% |
| 2013 FY | 228.37 Thousand USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Burzynski Research Institute, Inc. | 2310.00 USD | -112592.468% |
| Arch Therapeutics, Inc. | 1.95 Million USD | -32.939% |
| Evofem Biosciences, Inc. | 10.55 Million USD | 75.335% |
| Nascent Biotech, Inc. | 552.12 Thousand USD | -371.491% |
| Rebus Holdings, Inc. | 5000.00 USD | -51963.92% |
| Santhera Pharmaceuticals Holding AG | 130.21 Million USD | 98.001% |
| Qrons Inc. | 420.00 USD | -619708.571% |
| Adynxx, Inc. | - USD | -Infinity% |
| Neon Bloom, Inc. | 770.64 Thousand USD | -237.795% |
| Northwest Biotherapeutics, Inc. | 27.94 Million USD | 90.684% |
| ProtoKinetix, Incorporated | 480.55 Thousand USD | -441.704% |
| Skye Bioscience, Inc. | 11.94 Million USD | 78.198% |
| Eiger BioPharmaceuticals, Inc. | 38.84 Million USD | 93.299% |
| Nanobac Pharmaceuticals, Incorporated | 7.21 Million USD | 63.943% |
| Institute of Biomedical Research Corp. | 76.35 Thousand USD | -3309.377% |
| SQZ Biotechnologies Company | 107.18 Million USD | 97.571% |
| Intellipharmaceutics International Inc. | 1.43 Million USD | -81.783% |
| Propanc Biopharma, Inc. | 72.36 Thousand USD | -3497.314% |
| Mesoblast Limited | 667.9 Million USD | 99.61% |
| Marizyme, Inc. | 22.01 Million USD | 88.175% |
| Genus plc | 1.02 Billion USD | 99.747% |
| VioQuest Pharmaceuticals, Inc. | 1.35 Million USD | -91.644% |
| Pharming Group N.V. | 462.85 Million USD | 99.438% |
| Therapeutic Solutions International, Inc. | 3.31 Million USD | 21.425% |
| CNBX Pharmaceuticals Inc. | 499.03 Thousand USD | -421.642% |
| Nymox Pharmaceutical Corporation | 627 Thousand USD | -315.183% |
| ContraFect Corporation | 20.67 Million USD | 87.411% |
| PsyBio Therapeutics Corp. | 390.36 Thousand USD | -566.86% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 382.17 Thousand USD | -581.149% |
| IMV Inc. | 31.33 Million USD | 91.692% |
| AXIM Biotechnologies, Inc. | 4.14 Million USD | 37.212% |
| MultiCell Technologies, Inc. | 126.22 USD | -2062327.508% |
| ONE Bio Corp. | 70.08 Million USD | 96.286% |
| Accustem Sciences Inc. | 939.68 Thousand USD | -177.027% |
| RVL Pharmaceuticals plc | 128.51 Million USD | 97.974% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | 431.71 Thousand USD | -502.991% |
| Q BioMed Inc. | 3.51 Million USD | 25.951% |
| Emmaus Life Sciences, Inc. | 35.17 Million USD | 92.6% |
| Mosaic ImmunoEngineering Inc. | 261.27 Thousand USD | -896.336% |
| Biomind Labs Inc. | 73.81 Thousand USD | -3426.458% |
| American Oriental Bioengineering, Inc. | 446.3 Million USD | 99.417% |
| Provectus Biopharmaceuticals, Inc. | 1.44 Million USD | -79.674% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Oncotelic Therapeutics, Inc. | 30.01 Million USD | 91.327% |
| GlobeStar Therapeutics Corporation | - USD | -Infinity% |
| THC Farmaceuticals, Inc. | 2.74 Million USD | 5.212% |
| Acro Biomedical Co., Ltd. | 687.48 Thousand USD | -278.654% |
| GB Sciences, Inc. | 103.44 Thousand USD | -2416.575% |
| Alpha Cognition Inc. | 2.45 Million USD | -6.159% |
| HST Global, Inc. | 1526.00 USD | -170489.515% |
| CSL Limited | 38.02 Billion USD | 99.993% |
| Wesana Health Holdings Inc. | 987.96 Thousand USD | -163.49% |
| Halberd Corporation | 10.13 Thousand USD | -25595.351% |
| Enzolytics Inc. | 361.7 Million USD | 99.28% |
| Agentix Corp. | 261.39 Thousand USD | -895.897% |
| Resverlogix Corp. | 8.11 Million USD | 67.921% |
| Nuo Therapeutics, Inc. | 1.87 Million USD | -38.624% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | 4.54 Billion USD | 99.943% |
| Enzon Pharmaceuticals, Inc. | 47.7 Million USD | 94.543% |
| Endonovo Therapeutics, Inc. | 639.65 Thousand USD | -306.968% |
| RespireRx Pharmaceuticals Inc. | 22.78 Thousand USD | -11327.049% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | 8.94 Million USD | 70.911% |
| AVAX Technologies, Inc. | 7.37 Million USD | 64.713% |
| Zenith Capital Corp. | 7410.00 USD | -35030.85% |
| Genscript Biotech Corporation | 3.38 Billion USD | 99.923% |
| Ember Therapeutics, Inc. | 184.00 USD | -1414680.435% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 321.8 Thousand USD | -708.933% |
| WPD Pharmaceuticals Inc. | 261.36 Thousand USD | -896.004% |
| Cotinga Pharmaceuticals Inc. | 927.96 Thousand USD | -180.529% |
| Kadimastem Ltd | 2.3 Million USD | -12.982% |
| Helix BioMedix, Inc. | 3.02 Million USD | 13.946% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 52.7 Million USD | 95.06% |
| BioStem Technologies, Inc. | 14.56 Million USD | 82.121% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 57.09 Thousand USD | -4459.491% |
| LadRx Corporation | 2.3 Million USD | -12.796% |
| Cell Source, Inc. | 195.17 Thousand USD | -1233.803% |
| Regen BioPharma, Inc. | 353.61 Thousand USD | -636.163% |
| Regen BioPharma, Inc. | 353.61 Thousand USD | -636.163% |
| NovAccess Global Inc. | 62.24 Thousand USD | -4081.975% |
| Affymax, Inc. | 7.44 Million USD | 65.025% |
| Itoco Inc. | 1.4 Million USD | -85.933% |
| Rasna Therapeutics, Inc. | 95.65 Thousand USD | -2621.386% |
| Pathfinder Cell Therapy, Inc. | 106 Thousand USD | -2355.845% |
| Mobile Lads Corp. | 52.00 USD | -5006046.154% |
| CytoDyn Inc. | 11.13 Million USD | 76.624% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | 142.97 Thousand USD | -1720.773% |
| NanoSphere Health Sciences Inc. | 17.88 Thousand USD | -14459.262% |
| Alseres Pharmaceuticals, Inc. | 385.47 Thousand USD | -575.329% |
| SYBLEU INC | 330.46 Thousand USD | -687.73% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 409.42 Thousand USD | -535.822% |
| International Stem Cell Corporation | 5.39 Million USD | 51.703% |
| Bioxytran, Inc. | 137.63 Thousand USD | -1791.335% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 15 Million USD | 82.647% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | - USD | -Infinity% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 16.57 Million USD | 84.298% |
| Adhera Therapeutics, Inc. | 79 Thousand USD | -3195.185% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 864.67 Thousand USD | -201.06% |
| Innovation Pharmaceuticals Inc. | 7.51 Million USD | 65.369% |
| Neutra Corp. | 2851.00 USD | -91208.173% |
| Windtree Therapeutics, Inc. | 32.4 Million USD | 91.967% |
| PureTech Health plc | 693.97 Million USD | 99.625% |
| Coeptis Therapeutics, Inc. | 8.07 Million USD | 67.747% |
| IXICO plc | 15.84 Million USD | 83.57% |
| IntelGenx Technologies Corp. | 8.28 Million USD | 68.568% |
| Gelesis Holdings, Inc. | 103.32 Million USD | 97.481% |
| CSL Limited | 38.02 Billion USD | 99.993% |
| Cellectis S.A. | 333.99 Million USD | 99.221% |